Bio-Path Holdings, Inc.
US ˙ OTCPK

Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Gillian C Ivers-read. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Gillian C Ivers-read reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:CLVS / Clovis Oncology Inc See Remarks 293,612
US:BPTH / Bio-Path Holdings, Inc. Director 25,000
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Gillian C Ivers-read. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Compras Internas BPTH / Bio-Path Holdings, Inc. - Análise de Lucro de Curto Prazo

Nesta seção, analisamos a lucratividade de cada compra interna de mercado aberto, não planejada, feita em BPTH / Bio-Path Holdings, Inc.. Esta análise ajuda a entender se o interno gera consistentemente retornos anormais, e vale a pena seguir. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as compras de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Máx
Preço em
Máx
Lucro
Máx ($)
Retorno Máx (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Vendas Internas BPTH / Bio-Path Holdings, Inc. - Análise de Perda de Curto Prazo

Nesta seção, analisamos a evitação de perdas de curto prazo de cada venda interna de mercado aberto, não planejada feita em BPTH / Bio-Path Holdings, Inc.. Um padrão consistente de evitação de perdas pode sugerir que transações futuras de venda possam prever declínios no preço. Esta análise é para um ano seguinte a cada transação, e os resultados são teóricos.

A tabela a seguir mostra as vendas de mercado aberto mais recentes que não faziam parte de um plano de negociação automático.

Data de Negociação Ticker Insider Ações
Reportadas
Preço
Reportado
Ações
Ajustadas
Preço
Ajustado
Base de Custos Dias para
Mín
Preço em
Mín
Máxima Perda
Evitada ($)
Máxima Perda
Evitada (%)
Não há negociações abertas de mercado não planejadas conhecidas para esta combinação de insider e ativo

O Preço Ajustado é o preço ajustado pela divisão. Ações Ajustadas são as ações ajustadas pela divisão.

BPTH / Bio-Path Holdings, Inc. Insider Trades
Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Gillian C Ivers-read conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,006 293,612 -0.68 0.98 -1,972 288,591
2022-11-03 2022-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,675 290,993 -0.57 0.98 -1,646 286,017
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 295,618 1.59
2022-11-03 2022-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 292,668 1.30
2022-09-06 2022-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,234 288,919 -0.77 1.20 -2,681 346,703
2022-09-06 2022-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,063 291,153 1.77
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,100 286,090 -0.73 1.46 -3,068 417,977
2022-08-03 2022-08-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,702 283,565 -0.60 1.46 -2,487 414,288
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 288,190 1.63
2022-08-03 2022-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 285,267 1.33
2022-06-03 2022-06-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,327 281,518 -0.82 0.64 -1,495 180,847
2022-06-03 2022-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 5,062 283,845 1.82
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,062 278,783 -0.73 1.97 -4,062 549,147
2022-05-03 2022-05-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,671 276,220 -0.60 1.97 -3,292 544,098
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 32,375 -12.50
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 11,248 -25.00
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 280,845 1.67
2022-05-03 2022-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 277,891 1.37
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -10,416 274,142 -3.66 1.87 -19,436 511,549
2022-03-03 2022-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -354 264,308 -0.13 1.87 -661 493,199
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 0 -100.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 20,250 60,750 50.00
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 20,250 284,558 7.66
2022-03-03 2022-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 264,662 0.26
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,453 263,974 -0.92 1.94 -4,758 512,057
2022-02-03 2022-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,989 261,802 -0.75 1.94 -3,858 507,791
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 37,000 -11.11
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,750 14,997 -20.00
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 266,427 1.77
2022-02-03 2022-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,750 263,791 1.44
2021-12-03 2021-12-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 260,041 -0.12 3.00 -912 780,123
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 688 -49.96
2021-12-03 2021-12-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 260,345 0.26
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,041 259,658 -0.78 4.55 -9,287 1,181,444
2021-11-03 2021-11-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,655 257,074 -0.64 4.55 -7,530 1,169,687
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 41,625 -10.00
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 18,747 -16.67
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 261,699 1.80
2021-11-03 2021-11-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 258,729 1.47
2021-09-03 2021-09-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 254,980 -0.12 4.89 -1,487 1,246,852
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 1,375 -33.35
2021-09-03 2021-09-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 255,284 0.27
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,034 254,596 -0.79 4.82 -9,804 1,227,153
2021-08-03 2021-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,649 252,005 -0.65 4.82 -7,948 1,214,664
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 46,150 -9.11
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 22,496 -14.28
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 256,630 1.84
2021-08-03 2021-08-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 253,654 1.50
2021-06-03 2021-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -283 249,905 -0.11 5.63 -1,593 1,406,965
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 687 2,063 49.93
2021-06-03 2021-06-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 250,188 0.28
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -2,183 249,501 -0.87 5.54 -12,094 1,382,236
2021-05-04 2021-05-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,769 247,059 -0.71 5.54 -9,800 1,368,707
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -4,625 50,875 -8.33
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 26,245 -12.50
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 4,625 251,684 1.87
2021-05-04 2021-05-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 248,828 1.53
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 245,079 -0.12 6.29 -1,912 1,541,547
2021-03-03 2021-03-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -276 244,695 -0.11 6.29 -1,736 1,539,132
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 688 2,750 33.37
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise 625 0 -100.00
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 81,000 81,000
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 245,383 0.28
2021-03-03 2021-03-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 244,971 0.26
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9,031 244,346 -3.56 7.97 -71,977 1,947,438
2021-02-03 2021-02-02 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,959 234,877 -0.83 7.97 -15,613 1,871,970
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -18,500 55,500 -25.00
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,750 29,994 -11.11
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 18,500 253,377 7.88
2021-02-03 2021-02-01 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,750 236,836 1.61
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 0 -100.00
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 233,086 -0.35 5.68 -4,709 1,323,928
2020-12-23 2020-12-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 233,915 0.81
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Employee Stock Option (right to buy)
M - Exercise -68,965 0 -100.00
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -52,447 232,040 -18.44 4.81 -252,270 1,116,112
2020-12-14 2020-12-10 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 68,965 284,487 32.00 3.28 226,205 933,117
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 3,438 -16.65
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 625 -50.00
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -304 215,522 -0.14 4.89 -1,487 1,053,903
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 215,826 0.32
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -277 215,139 -0.13 4.89 -1,355 1,052,030
2020-12-07 2020-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 215,416 0.29
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 33,744 -10.00
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,689 214,791 -0.78 4.93 -8,327 1,058,920
2020-11-05 2020-11-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 216,480 1.76
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 1,875 -50.00
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 212,731 -0.39 6.85 -5,679 1,457,207
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -9 213,560 0.00 6.86 -62 1,465,022
2020-09-23 2020-09-21 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 213,569 0.89
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 4,125 -14.29
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1,250 -33.33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -290 211,694 -0.14 5.30 -1,537 1,121,978
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 211,984 0.33
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -263 211,296 -0.12 5.30 -1,394 1,119,869
2020-09-08 2020-09-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 211,559 0.30
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 37,493 -9.09
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,670 210,934 -0.79 5.92 -9,886 1,248,729
2020-08-05 2020-08-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 212,604 1.80
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 3,750 -33.33
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 208,855 -0.40 6.74 -5,587 1,407,683
2020-06-23 2020-06-22 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 209,684 0.90
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 4,813 -12.49
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 1,875 -25.00
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -313 207,809 -0.15 7.03 -2,200 1,460,897
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 208,122 0.33
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -285 207,435 -0.14 7.03 -2,004 1,458,268
2020-06-05 2020-06-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 207,720 0.30
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -3,749 41,242 -8.33
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,475 207,095 -0.71 8.10 -11,948 1,677,470
2020-05-07 2020-05-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 3,749 208,570 1.83
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 5,625 -25.00
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 204,821 -0.40 4.60 -3,813 942,177
2020-03-23 2020-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 205,650 0.92
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 5,500 -11.12
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 2,500 -20.00
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -317 203,775 -0.16 7.20 -2,282 1,467,180
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 204,092 0.34
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -288 203,404 -0.14 7.20 -2,074 1,464,509
2020-03-05 2020-03-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 203,692 0.31
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -14,997 44,991 -25.00
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -7,204 203,067 -3.43 8.41 -60,586 1,707,793
2020-02-06 2020-02-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 14,997 210,271 7.68
2020-01-31 2020-01-31 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 74,000 74,000
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 7,500 -20.00
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -830 195,274 -0.42 11.30 -9,379 2,206,596
2019-12-26 2019-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 196,104 0.97
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 6,188 -9.99
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3,125 -16.67
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -310 194,229 -0.16 14.59 -4,523 2,833,801
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 194,539 0.35
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -282 193,852 -0.15 14.60 -4,117 2,830,239
2019-12-05 2019-12-03 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 194,134 0.32
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 9,375 -16.67
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -837 193,509 -0.43 4.80 -4,018 928,843
2019-09-24 2019-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 194,346 0.97
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -688 6,875 -9.10
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 3,750 -14.29
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -330 192,471 -0.17 5.21 -1,719 1,002,774
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 688 192,801 0.36
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -300 192,113 -0.16 5.21 -1,563 1,000,909
2019-09-06 2019-09-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 192,413 0.33
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 11,250 -14.29
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 191,788 -0.43 14.70 -12,186 2,819,284
2019-06-24 2019-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 192,617 0.98
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -687 7,563 -8.33
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 4,375 -12.50
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -302 190,742 -0.16 15.07 -4,551 2,874,482
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 687 191,044 0.36
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -275 190,357 -0.14 15.07 -4,144 2,868,680
2019-06-06 2019-06-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 190,632 0.33
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 13,125 -12.50
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -830 190,007 -0.43 26.13 -21,688 4,964,883
2019-03-21 2019-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 190,837 0.99
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,750 8,250 -25.00
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5,000 -11.11
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -1,295 188,962 -0.68 29.29 -37,931 5,534,697
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,750 190,257 1.47
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -316 187,507 -0.17 29.29 -9,256 5,492,080
2019-03-06 2019-03-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 187,823 0.33
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 59,988 59,988
2019-02-04 2019-02-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 19,996 19,996
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 15,000 -11.11
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -829 187,198 -0.44 17.72 -14,690 3,317,149
2018-12-26 2018-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 188,027 1.01
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 5,625 -10.00
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -250 186,152 -0.13 21.23 -5,308 3,952,007
2018-12-06 2018-12-04 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 186,402 0.34
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 16,875 -10.00
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 185,777 -0.44 32.21 -26,702 5,983,877
2018-09-24 2018-09-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 186,606 1.01
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6,250 -9.09
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -282 184,731 -0.15 35.75 -10,082 6,604,133
2018-09-07 2018-09-05 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 185,013 0.34
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 18,750 -9.09
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 184,388 -0.45 45.75 -37,927 8,435,751
2018-06-21 2018-06-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 185,217 1.02
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -625 6,875 -8.33
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -278 183,342 -0.15 47.70 -13,261 8,745,413
2018-06-08 2018-06-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 625 183,620 0.34
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -1,875 20,625 -8.33
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -829 182,995 -0.45 56.75 -47,046 10,384,966
2018-03-21 2018-03-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 1,875 183,824 1.03
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -2,500 7,500 -25.00
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -1,122 181,949 -0.61 58.43 -65,558 10,631,280
2018-03-07 2018-03-06 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 2,500 183,071 1.38
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 11,000 11,000
2018-03-02 2018-03-01 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 11,000 11,000
2018-02-16 2018-02-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 180,571 -1.63 54.09 -162,270 9,767,085
2018-01-17 2018-01-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 183,571 -1.61 59.16 -177,480 10,860,060
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
M - Exercise -7,500 22,500 -25.00
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
F - Taxes -3,512 186,571 -1.85 63.80 -224,066 11,903,230
2017-12-21 2017-12-20 4 CLVS Clovis Oncology, Inc.
Common Stock
M - Exercise 7,500 190,083 4.11
2017-12-18 2017-12-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 182,583 -1.62 64.16 -192,480 11,714,525
2017-11-16 2017-11-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 185,583 -1.59 63.70 -191,100 11,821,637
2017-10-17 2017-10-16 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 188,583 -1.57 84.54 -253,620 15,942,807
2017-09-18 2017-09-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 191,583 -1.54 69.50 -208,500 13,315,018
2017-08-15 2017-08-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 194,583 -1.52 70.05 -210,150 13,630,539
2017-07-17 2017-07-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 197,583 -1.50 91.56 -274,680 18,090,699
2017-06-15 2017-06-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 200,583 -1.47 61.82 -185,460 12,400,041
2017-05-15 2017-05-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 203,583 -1.45 47.39 -142,170 9,647,798
2017-04-17 2017-04-17 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 206,583 -1.43 56.02 -168,060 11,572,780
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 10,000 10,000
2017-03-28 2017-03-27 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2017-03-15 2017-03-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 209,583 -1.41 66.99 -200,970 14,039,965
2016-12-19 2016-12-19 4 CLVS Clovis Oncology, Inc.
Restricted Stock Units
A - Award 30,000 30,000
2016-09-19 2016-09-16 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
J - Other -8,750 26,250 -25.00
2015-10-16 2015-10-15 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 212,583 -1.39 91.91 -275,730 19,538,504
2015-09-22 2015-09-18 4 CLVS Clovis Oncology, Inc.
Common Stock
S - Sale -3,000 215,583 -1.37 112.56 -337,680 24,266,022
2015-03-04 2015-03-02 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 35,000 35,000
2014-04-28 2014-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2014-01-14 2014-01-10 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 70,000 70,000
2013-04-26 2013-04-25 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2013-03-04 2013-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 75,000 75,000
2013-02-21 2013-02-19 4 BPTH BIO-PATH HOLDINGS INC
Stock Option
A - Award 25,000 25,000
2012-03-05 2012-03-01 4 CLVS Clovis Oncology, Inc.
Stock Option (right to buy)
A - Award 50,000 50,000
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)